News
Nueva píldora contra obesidad de Novo Nordisk, Amycretin, supera a Wegovy en un ensayo inicial
La esperadísima nueva píldora contra la obesidad muestra un potencial para una mayor y más rápida pérdida de peso que Wegovy.
![[Imágenes: Freepik]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/04085610/p-91535461-europe-counter-drone-threat.webp)
![[Imagen: CSA-Images/Getty Images]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/04095942/p-1-91533937-filmmakers-ai-tools-e1777910437872.webp)
![[Foto: Rockstar Games]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/04082230/p-91534908-take-two-interactive.webp)
![[Imágenes de origen: Pixabay]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/04100616/p-91534390-6-in-10-workers-claim-to-have-a-toxic-boss.webp)
